Analyst Ratings for Unum Therapeutics (UMRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/2/2020 | Jefferies | N/A | New Coverage | Buy (N/A) |
4.00 (N/A) |
2.34 (2.35) |
0.43% | Details |
| 7/7/2020 | Wedbush | David Nierengarten | Upgrade | Outperform (Neutral) |
4.00 (1.00) |
2.20 (2.35) |
6.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
